Paper39940134
Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.
Spada A and 1 other. Nanomaterials (Basel), 2025. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting. Papers, record 39940134. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39940134
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Surface Functionalization of Nanocarriers with Anti-EGFR Ligands for Cancer Active Targeting.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 200021E_205754 | Swiss National Science Foundation | Switzerland | PubMed |
Source PubMed
References320
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33390415 | Epidermal Growth Factor-gold Nanoparticle Conjugates-induced Cellular Responses: Effect of Interfacial Parameters between Cell and Nanoparticle. | Anal Sci | 2021 | https://conductscience.org/library/papers/33390415 | PubMed |
| 2 | 37814270 | Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37814270 | PubMed |
| 3 | 21627112 | Biomedical applications of tetrazine cycloadditions. | Acc Chem Res | 2011 | https://conductscience.org/library/papers/21627112 | PubMed |
| 4 | 12651129 | Immobilization and surface characterization of NeutrAvidin biotin-binding protein on different hydrogel interlayers. | J Colloid Interface Sci | 2003 | https://conductscience.org/library/papers/12651129 | PubMed |
| 5 | 34853120 | Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis of Proteins. | Cold Spring Harb Protoc | 2021 | https://conductscience.org/library/papers/34853120 | PubMed |
| 6 | 10862985 | Ligands selected from combinatorial libraries of protein A for use in affinity capture of apolipoprotein A-1M and taq DNA polymerase. | J Biotechnol | 2000 | https://conductscience.org/library/papers/10862985 | PubMed |
| 7 | 37114242 | A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti-tumor response. | Oncoimmunology | 2023 | https://conductscience.org/library/papers/37114242 | PubMed |
| 8 | 22586147 | Tumor targeting using affibody molecules: interplay of affinity, target expression level, and binding site composition. | J Nucl Med | 2012 | https://conductscience.org/library/papers/22586147 | PubMed |
| 9 | 36321150 | Mapping the relationship between total and functional antibodies conjugated to nanoparticles with spectrally-resolved direct stochastic optical reconstruction microscopy (SR-dSTORM). | Nanoscale Adv | 2022 | https://conductscience.org/library/papers/36321150 | PubMed |
| 10 | 39525567 | Recent advances in aptamer discovery, modification and improving performance. | Biochem Biophys Rep | 2024 | https://conductscience.org/library/papers/39525567 | PubMed |
| 11 | 18698735 | Cu-catalyzed azide-alkyne cycloaddition. | Chem Rev | 2008 | https://conductscience.org/library/papers/18698735 | PubMed |
| 12 | 39154445 | A computer-aided, heterodimer-based "triadic" carrier-free drug delivery platform to mitigate multidrug resistance in lung cancer and enhance efficiency. | J Colloid Interface Sci | 2025 | https://conductscience.org/library/papers/39154445 | PubMed |
| 13 | 32498278 | Particle-Size-Dependent Delivery of Antitumoral miRNA Using Targeted Mesoporous Silica Nanoparticles. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32498278 | PubMed |
| 14 | 39468359 | Targeted protein degradation via cellular trafficking of nanoparticles. | Nat Nanotechnol | 2025 | https://conductscience.org/library/papers/39468359 | PubMed |
| 15 | 15880677 | Chemical synthesis of triple-labelled three-helix bundle binding proteins for specific fluorescent detection of unlabelled protein. | Chembiochem | 2005 | https://conductscience.org/library/papers/15880677 | PubMed |
| 16 | 11433435 | Click Chemistry: Diverse Chemical Function from a Few Good Reactions. | Angew Chem Int Ed Engl | 2001 | https://conductscience.org/library/papers/11433435 | PubMed |
| 17 | 18581754 | Epidermal growth factor therapy and wound healing--past, present and future perspectives. | Surgeon | 2008 | https://conductscience.org/library/papers/18581754 | PubMed |
| 18 | 32698317 | Monoclonal Antibodies in Cancer Therapy. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/32698317 | PubMed |
| 19 | 33800717 | In Vivo Production of RNA Aptamers and Nanoparticles: Problems and Prospects. | Molecules | 2021 | https://conductscience.org/library/papers/33800717 | PubMed |
| 20 | 5319841 | Streptavidin--a substance with avidin-like properties produced by microorganisms. | Biochem Biophys Res Commun | 1964 | https://conductscience.org/library/papers/5319841 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42942844 | Cell Membrane-Coated Nanoparticles as Biomimetic Drug Delivery Systems: Design, Therapeutic Applications, and Translational Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942844 | PubMed |
| 42700019 | Chitosan-based nanoparticles as a targeted drug delivery system to treat thyroid cancer: A literature review. | Medicine (Baltimore) | 2026 | https://conductscience.org/library/papers/42700019 | PubMed |
| 42699688 | Nanoparticle-Based miRNA Therapeutics in Breast Cancer Highlighting Design Strategies and Translational Potential. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42699688 | PubMed |
| 42653769 | Gold Nanoparticles in Prostate Cancer: Advances in Targeted Therapy, Diagnostics, and Precision Nanomedicine. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653769 | PubMed |
| 42627480 | Theranostic Smart Bionanosensors for Solid Tumors: Advances, Challenges, and Future Directions. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/42627480 | PubMed |
| 42620963 | Orthogonal functionalization of lithium niobate nanoparticles with targeting aptamers and caged chemotherapeutics. | RSC Appl Interfaces | 2026 | https://conductscience.org/library/papers/42620963 | PubMed |
| 42545662 | Sensitive detection of unopposed estrogen using estrogen receptor functionalized nanoprobes for cancer diagnosis. | Discov Nano | 2026 | https://conductscience.org/library/papers/42545662 | PubMed |
| 42460644 | Isothiocyanates in Cancer Therapeutics - A Molecular Perspective. | Chem Biodivers | 2026 | https://conductscience.org/library/papers/42460644 | PubMed |
| 42357313 | Cell-Specific Extracellular Vesicles Targeting Strategies for Immune Modulation in Inflammatory Diseases. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42357313 | PubMed |
| 42351104 | Virus-like particles in cancer immunotherapy: bridging human and veterinary medicine through one health. | J Nanobiotechnology | 2026 | https://conductscience.org/library/papers/42351104 | PubMed |
| 42260240 | Emerging paradigms in nanostructured targeted drug delivery systems. | Discov Nano | 2026 | https://conductscience.org/library/papers/42260240 | PubMed |
| 42232345 | Bio-based nanomaterials in drug delivery: An updated review. | Pharm Sci Adv | 2026 | https://conductscience.org/library/papers/42232345 | PubMed |
| 42071161 | Engineering microspheres for breast cancer: integrating tumor modeling, diagnostics, and targeted treatment. | Daru | 2026 | https://conductscience.org/library/papers/42071161 | PubMed |
| 41956789 | [Exploration and application of nanotechnology in precision transarterial chemoembolization for hepatocellular carcinoma]. | Zhonghua Gan Zang Bing Za Zhi | 2026 | https://conductscience.org/library/papers/41956789 | PubMed |
| 41922813 | Cationic lipid-based nanoparticles for therapeutic delivery in cancer treatment: physicochemical characteristics, therapeutic cargos, and clinical potential. | Appl Microsc | 2026 | https://conductscience.org/library/papers/41922813 | PubMed |
| 41710748 | Peptide-Functionalized Liposomal Nanocarriers for Targeted Therapy of Liver Fibrosis and Hepatocellular Carcinoma: Design, Mechanisms, and Clinical Prospects. | ACS Pharmacol Transl Sci | 2026 | https://conductscience.org/library/papers/41710748 | PubMed |
| 41499069 | Co-encapsulation in Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as an Emerging Therapeutic Strategy. | Mol Diagn Ther | 2026 | https://conductscience.org/library/papers/41499069 | PubMed |
| 41409587 | Allosteric ligand-driven smart nanoconjugates for mutation-selective EGFR targeting: A precision approach to overcoming tyrosine kinase inhibitor resistance. | Bioimpacts | 2025 | https://conductscience.org/library/papers/41409587 | PubMed |
| 41246347 | Sulforaphane in cancer precision medicine: from biosynthetic origins to multiscale mechanisms and clinical translation. | Front Immunol | 2025 | https://conductscience.org/library/papers/41246347 | PubMed |
| 41184856 | Antibody-drug conjugates in cancer therapy: current landscape, challenges, and future directions. | Mol Cancer | 2025 | https://conductscience.org/library/papers/41184856 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39940134
GET https://conductscience.org/api/papers/v1/39940134/references?page=2